FDA Adverse Event Injury Summary report: N

1-DAY ACUVUE TRUEYE NARAFILCON A

MDR report key: 1936033 · Received December 13, 2010

Report

Report Number
1033553-2010-00156
Event Type
Injury
Date Received
December 13, 2010
Date of Event
September 2, 2010
Report Date
December 13, 2010
Manufacturer
VISTAKON
Product Code
LPL
PMA / PMN Number
K073485
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

DEVICE NOT RETURNED. NO EVALUATION WILL BE PERFORMED. NO CONCLUSION CAN BE DRAWN.

Description of Event or Problem · 1

OUR (B)(4) AFFILIATE RECEIVED INFO FROM A CONTACT LENS (CL) SALES SHOP ON (B)(6) 2010 INDICATING A PT DEVELOPED A CORNEAL ULCER IN SEPTEMBER WHILE WEARING 1-DAY ACUVUE TRUEYE CONTACT LENSES (NARAFILCON A). NARAFILCON A CONTACT LENSES ARE NOT MARKETED IN THE UNITED STATES. THE BANDO EYE CLINIC, WHERE THE PT RECEIVED TREATMENT, WAS CONTACTED ON (B)(6) 2010 AND AN APPOINTMENT FOR A FACE-TO-FACE INTERVIEW WAS SCHEDULED FOR (B)(6) 2010. ON (B)(6) 2010, AN ASSOCIATE FROM OUR (B)(4) AFFILIATE MET THE TREATING ECP AND RECEIVED THE FOLLOWING INFO: THE PT WAS INITIALLY SEEN ON (B)(6) 2010. THE PT COMPLAINED OF RIGHT EYE (OD) PAIN IN THE MIDDLE OF THE NIGHT ON (B)(6) 2010. THE PT ALSO COMPLAINED OF OD REDNESS AND A WHITE DOT IN THE OD. THE PT WAS DIAGNOSED WITH A 0.5 MM CORNEAL INFILTRATE OD. THE INFILTRATE WAS PERIPHERAL AND LOCATED AT 4 O'CLOCK. THE ECP PRESUMED THE INFILTRATE WAS INFECTIOUS, BUT THE INFILTRATE WAS NOT CULTURED. THE PT'S VA WAS NOT MEASURED, BUT THE ECP NOTED THAT THE OD VA WAS NOT AFFECTED. THE PT WAS TREATED WITH GATIFLO, AVELOX AND HYALEIN EYE DROPS AND MAXIPIME 1G IV. ON (B)(6) 2010 THE PT RETURNED TO BANDO EYE CLINIC. THE PT STILL HAD A LITTLE DISCOMFORT. THERE WAS A LEUCOMA WHICH WAS SMALLER THAN THE CORNEAL INFILTRATE. THE PT CONTINUED TREATMENT WITH THE EYE DROPS. THE PT'S VA WAS NOT MEASURED. ON (B)(6) 2010, THE PT RETURNED TO THE EYE CLINIC. THE PT'S CONDITION HAD MUCH IMPROVED. THE PT'S VA WAS NOT MEASURED. THE PT CONTINUED TO BE TREATED WITH GATIFLO AND HYALEIN EYE DROPS. THE PT REQUESTED TO RESUME CL WEAR AND WAS PRESCRIBED 1-DAY ACUVUE MOIST CONTACT LENSES AND ALLOWED TO WEAR THEM FOR A SHORT TIME. ON (B)(6) 2010, THE PT RETURNED TO THE EYE CLINIC. THERE WAS A SLIGHT, RESIDUAL, CORNEAL SCAR. THE ECP DETERMINED THAT THE PT RECOVERED AND THE PT WAS PRESCRIBED 1-DAY ACUVUE MOIST CONTACT LENSES. THE PRODUCT AND LOT# WERE NOT PROVIDED. IF ADDITIONAL INFO IS RECEIVED, WE WILL REPORT IT WITHIN 30 DAYS OF RECEIPT. MDR REPORTABLE EVENT TRENDS ARE REVIEWED QUARTERLY IN EXECUTIVE MANAGEMENT REVIEW MEETINGS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 1-DAY ACUVUE TRUEYE NARAFILCON A SOFT CONTACT LENS LPL VISTAKON NA UNK

Patients

Seq Age Sex Outcome Treatment
1 51 YR Other| R